Skip to content

Clinical trials

Completed Cholangiocarcinoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Completed Country / region: Netherlands Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20162
20171
20181
20191
20201
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Merck Sharp & Dohme LLC2
Bayer1
Boston Scientific Corporation1
Elevar Therapeutics1
Erasmus Medical Center1
Hoffmann-La Roche1
Leiden University Medical Center1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Gallbladder Neoplasms2
Pancreatic Neoplasms2
Stomach Neoplasms2
Triple Negative Breast Neoplasms2
Urinary Bladder Neoplasms2
Adenocarcinoma1
Bile Duct Neoplasms1
Breast Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.